Sinsin Pharmaceutical Co. Ltd Cash Flow Conversion Efficiency
Sinsin Pharmaceutical Co. Ltd cash flow conversion efficiency. Based on the latest financial reports, Sinsin Pharmaceutical Co. Ltd (002800) has a cash flow conversion efficiency ratio of 0.066x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩4.70 Billion ≈ $3.18 Million USD) by net assets (₩71.01 Billion ≈ $48.12 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Sinsin Pharmaceutical Co. Ltd (2016–2024)
Cash flow conversion efficiency of Sinsin Pharmaceutical Co. Ltd from 2016 to 2024. This chart illustrates how Sinsin Pharmaceutical Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Sinsin Pharmaceutical Co. Ltd (002800) stock price for real-time trading data and today's change.
Sinsin Pharmaceutical Co. Ltd Cash Flow Conversion Ratio Explained
Sinsin Pharmaceutical Co. Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Sinsin Pharmaceutical Co. Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Sinsin Pharmaceutical Co. Ltd ranked by their cash flow conversion efficiency. Also see market cap of Sinsin Pharmaceutical Co. Ltd for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Yura Tech. Co. Ltd
KQ:048430
|
0.021x |
|
Petershill Partners PLC
LSE:PHLL
|
0.014x |
|
Heungkuk Metaltech Co.Ltd
KQ:010240
|
0.061x |
|
ENDURANCE MOTIVE EO -02
F:7VB
|
N/A |
|
Song Ho Industrial Co Ltd
TWO:5016
|
0.013x |
|
EPE Capital Partners Ltd
JSE:EPE
|
-0.059x |
|
Lion One Metals Limited
V:LIO
|
-0.011x |
|
Sealink International Bhd
KLSE:5145
|
-0.080x |
Annual Cash Flow Conversion Efficiency for Sinsin Pharmaceutical Co. Ltd (2016–2024)
The table below shows the annual cash flow conversion efficiency of Sinsin Pharmaceutical Co. Ltd from 2016 to 2024. Review how much free cash does Sinsin Pharmaceutical Co. Ltd generate to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩65.87 Billion ≈ $44.64 Million |
₩5.94 Billion ≈ $4.03 Million |
0.090x | +42.55% |
| 2023-12-31 | ₩62.09 Billion ≈ $42.08 Million |
₩3.93 Billion ≈ $2.66 Million |
0.063x | -30.80% |
| 2022-12-31 | ₩59.70 Billion ≈ $40.46 Million |
₩5.46 Billion ≈ $3.70 Million |
0.091x | +21570.98% |
| 2021-12-31 | ₩54.93 Billion ≈ $37.22 Million |
₩23.18 Million ≈ $15.71K |
0.000x | -98.73% |
| 2020-12-31 | ₩56.20 Billion ≈ $38.08 Million |
₩1.87 Billion ≈ $1.26 Million |
0.033x | +141.52% |
| 2019-12-31 | ₩56.36 Billion ≈ $38.20 Million |
₩-4.51 Billion ≈ $-3.05 Million |
-0.080x | -663.11% |
| 2018-12-31 | ₩54.54 Billion ≈ $36.96 Million |
₩774.24 Million ≈ $524.69K |
0.014x | -83.80% |
| 2017-12-31 | ₩52.12 Billion ≈ $35.32 Million |
₩4.57 Billion ≈ $3.10 Million |
0.088x | +8.00% |
| 2016-12-31 | ₩34.43 Billion ≈ $23.33 Million |
₩2.79 Billion ≈ $1.89 Million |
0.081x | -- |
About Sinsin Pharmaceutical Co. Ltd
Sinsin Pharmaceutical Co., Ltd manufactures and sells pharmaceutical products in South Korea. It offers various medicinal products, such as plaster, aerosol, topical liquid, emollient, hygiene, and ointment products, as well as adhesive bandages, mosquito repellents, anti-perspirants, cooling sheets, bruise treatment creams, and other products. The company also develops transdermal drug delivery … Read more